Genprex Statistics

Total Valuation

Genprex has a market cap or net worth of $3.41 million. The enterprise value is $1.86 million.

Market Cap	3.41M
Enterprise Value	1.86M

Important Dates

The next estimated earnings date is Monday, March 31, 2025, after market close.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Genprex has 8.51 million shares outstanding. The number of shares has increased by 69.37% in one year.

Current Share Class	8.51M
Shares Outstanding	8.51M
Shares Change (YoY)	+69.37%
Shares Change (QoQ)	+61.88%
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	4.98%
Float	8.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.30
P/TBV Ratio	2.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.86

Current Ratio	0.86
Quick Ratio	0.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -325.11% and return on invested capital (ROIC) is -204.23%.

Return on Equity (ROE)	-325.11%
Return on Assets (ROA)	-138.83%
Return on Invested Capital (ROIC)	-204.23%
Return on Capital Employed (ROCE)	-1,370.91%
Revenue Per Employee	n/a
Profits Per Employee	-$873,460
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.84% in the last 52 weeks. The beta is -0.95, so Genprex's price volatility has been lower than the market average.

Beta (5Y)	-0.95
52-Week Price Change	-90.84%
50-Day Moving Average	0.73
200-Day Moving Average	1.30
Relative Strength Index (RSI)	23.72
Average Volume (20 Days)	1,546,345

Short Selling Information

The latest short interest is 186,657, so 2.19% of the outstanding shares have been sold short.

Short Interest	186,657
Short Previous Month	261,286
Short % of Shares Out	2.19%
Short % of Float	2.20%
Short Ratio (days to cover)	0.50

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.83M
Pretax Income	-27.63M
Net Income	-22.71M
EBITDA	-22.82M
EBIT	-22.83M
Earnings Per Share (EPS)	-$10.34

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	1.49M
Total Debt	n/a
Net Cash	1.49M
Net Cash Per Share	$0.17
Equity (Book Value)	1.66M
Book Value Per Share	0.30
Working Capital	-324,791

Full Balance Sheet

Cash Flow

Operating Cash Flow	-18.24M
Capital Expenditures	n/a
Free Cash Flow	-18.24M
FCF Per Share	-$2.14

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genprex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-69.37%
Shareholder Yield	-69.37%
Earnings Yield	-679.02%
FCF Yield	-545.47%

Analyst Forecast

The average price target for Genprex is $10.00, which is 2,391.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	2,391.90%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 2, 2024. It was a reverse split with a ratio of 0.025:1.

Last Split Date	Feb 2, 2024
Split Type	Reverse
Split Ratio	0.025:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1